Abstract
Targeted genome editing is an advanced technique that enables precise modification of the nucleic acid sequences in a genome. Genome editing is typically performed using tools, such as molecular scissors, to cut a defined location in a specific gene. Genome editing has impacted various fields of biotechnology, such as agriculture; biopharmaceutical production; studies on the structure, regulation, and function of the genome; and the creation of transgenic organisms and cell lines. Although genome editing is used frequently, it has several limitations. Here, we provide an overview of well-studied genome-editing nucleases, including single-stranded oligodeoxynucleotides (ssODNs), transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs), and CRISPR-Cas9 RNA-guided nucleases (CRISPR-Cas9). To this end, we describe the progress toward editable nuclease-based therapies and discuss the minimization of off-target mutagenesis. Future prospects of this challenging scientific field are also discussed.
Original language | English |
---|---|
Pages (from-to) | 212-238 |
Number of pages | 27 |
Journal | Molecular Therapy - Nucleic Acids |
Volume | 14 |
Early online date | 6 Dec 2018 |
DOIs | |
Publication status | Published - 1 Mar 2019 |
Bibliographical note
Funding Information:This work was supported by the KU-Research Professor Program of Konkuk University . This study was partially supported by a grant from the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning , South Korea (grant 2016R1E1A1A01940995 ).
Publisher Copyright:
© 2018 The Author(s)
Keywords
- CRISPR-Cas9
- DSB
- genome editing
- HDR
- NHEJ
- nucleases
- off-target mutagenesis
- ssODNs
- TALENs
- ZFNs